Comment from GE Healthcare Inc.

Summary: GE HealthCare supports the FDA's draft guidance on using AI for regulatory decision-making and appreciates the agency's recommendations. The company suggests that the FDA also consider incorporating the Failure Mode and Effects Analysis (FMEA) framework as a systematic approach for identifying, evaluating, and mitigating risks associated with AI models.